BMAL1 and colorectal cancer: Moreover, high BMAL1 expression is associated with increased sensitivity of colorectal cancer cells to oxaliplatin in vitro and in vivo, and predicts favorable outcome for patients treated with oxaliplatin-based chemotherapy (72).